30-Second Takeaway
- mHealth with human support yields modest BMI z-score reductions in pediatric obesity.
- Well-appearing febrile infants 60–90 days have an IBI prevalence near **1%**.
Week ending May 30, 2026
Five recent pediatric studies with immediate clinical relevance
mHealth plus human support modestly lowers BMI z-score in pediatric obesity
Systematic review of 23 RCTs, meta-analysis of six trials found BMI z-score MD -0.20 (95% CI -0.36 to -0.04; p=0.02). Behavioral outcomes (diet quality, sedentary time) improved more consistently than anthropometry. Engagement declined in standalone digital programs, while hybrid models with human support sustained effects. Body-composition data were sparse, limiting inference about true adiposity change beyond BMI.
Higher early parenteral amino acids linked to more short-term morbidity in extremely preterm infants
Secondary cohort of the ProVIDe trial (n=382) found higher week-1 amino acid intakes associated with increased odds of BPD, PDA, and probable sepsis. Specific amino acids (tyrosine, proline) showed ORs ≈ 2.2–2.3 for bronchopulmonary dysplasia. Higher early lipid intake was associated with lower odds of IVH, BPD, and ROP (example OR for IVH 0.33). Neurodevelopment at 2 years did not differ across early amino acid or intake quartiles.
Home-based exercise improves aerobic capacity in children with chronic disease
Systematic review of 81 studies (2923 participants) and meta-analysis of 19 RCTs found increased aerobic capacity (SMD 0.53; 95% CI 0.32–0.74; p<0.0001). No consistent benefit was found for functional capacity or quality of life versus controls. Adherence was generally high (>80% in many studies), supporting feasibility of home programs. Poor reporting quality and risk of bias limit certainty about strength and safety outcomes.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.